Sort
48,018 grants matching “immunotherapy”
Practical delivery of geriatric assessment in community oncology settings
$675,867Hannah Arem · Medstar Health Research Institute · UG3 · FY2025 · CA
Multiscale systems biology modeling to exploit tumor-stromal metabolic crosstalk in colorectal cancer
$675,822Stacey Deleria Finley · University Of Southern California · U01 · FY2019 · CA
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
$675,709Richard J Price · University Of Virginia · R01 · FY2020 · EB
New tools for quantitative non-invasive recording of biochemical signals
$675,594Nathan Christopher Shaner · University Of California, San Diego · R01 · FY2024 · CA
Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction
$675,462Gal Shafirstein · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Single-cell DNA methylation analysis of human cancer
$675,454Kenneth Aldape · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Adipocyte PD-L1 in the Breast Tumor Microenvironment
$675,405Rong Li · George Washington University · R01 · FY2024 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$675,300Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$675,300Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$675,300Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2020 · CA
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
$675,289Anna Karolina Palucka · Jackson Laboratory · R01 · FY2021 · CA
Synthetic toolkit for precision gene expression control and signal processing in mammalian cells
$675,046Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2022 · EB
Synthetic toolkit for precision gene expression control and signal processing in mammalian cells
$675,046Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2023 · EB
Rewiring T cell exhaustion with immune checkpoint blockade therapy
$674,996Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
Rewiring T cell exhaustion with immune checkpoint blockade therapy
$674,996Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
BRONX/LEBANON PEDIATRIC ACTU
$674,895Bronx-Lebanon Hosp Ctr (Bronx, Ny) · U01 · FY2000 · AI
Immunogenetic determinants of cancer risk
$674,787Robert M Samstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
3D Microscopy with Ultraviolet Surface Excitation (3D-MUSE)
$674,593David L Wilson · Case Western Reserve University · R01 · FY2022 · EB
Identification of genomic drivers of brain metastases in lung adenocarcinoma
$674,587Priscilla Kaliopi Brastianos · Massachusetts General Hospital · R01 · FY2019 · CA
Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma
$674,537Timothy A Marlowe · Faknostics, Llc · R42 · FY2021 · CA
Adoptive Transfer of MART-1 TCR Engineered Cells after a Myelodepleting Regimen
$674,507Antoni Ribas · California Institute Of Technology · P01 · FY2012 · CA
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$674,402Shabaana A. Khader · Washington University · R01 · FY2021 · AI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$674,402Shabaana A. Khader · Washington University · R01 · FY2019 · AI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$674,402Shabaana A. Khader · Washington University · R01 · FY2020 · AI
Phase I Clinical Trials of Anticancer Agents
$674,349Mayo Clinic Coll Of Medicine, Rochester · U01 · FY2003 · CA